Zivo Bioscience, Inc. SEC filings ZIVO
Zivo Bioscience, Inc. has 757 filings in SEC EDGAR's recent list, going back to Apr 20, 2000. Its latest annual report, Form ARS, was filed on Apr 25, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Mar 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Apr 24, 2026 | Apr 17, 2026 |
| EFFECT | Filing | Apr 1, 2026 | — |
| 15-12G | Deregistration | Mar 31, 2026 | — |
| S-8 POS | S-8 | Mar 31, 2026 | — |
| POS AM | Filing | Mar 31, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 30, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 27, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 14, 2026 |
| 3 | Initial insider ownership | Dec 29, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Nov 28, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 20, 2025 | Oct 13, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 14, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 9, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| 4 | Insider transaction | Apr 9, 2025 | Apr 8, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Jan 22, 2025 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Jan 27, 2025 | Jan 22, 2025 |
| 5 | Annual insider ownership | Jan 23, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 21, 2025 | Jan 17, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 15, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Dec 31, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 15, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Oct 18, 2024 | Oct 17, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 16, 2024 |
| 3 | Initial insider ownership | Oct 1, 2024 | Jul 11, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 1, 2024 | — |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| SC 13D | Ownership over 5% (active) | Jun 12, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jun 12, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jun 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 7, 2024 | — |
| 8-K/A |
Amended current report
Material agreement
|
Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jun 6, 2024 | May 31, 2024 |
| UPLOAD | Letter from the SEC | Jun 5, 2024 | — |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| CORRESP | Letter to the SEC | May 31, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| UPLOAD | Letter from the SEC | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 9, 2024 | — |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 14, 2024 | — |
| 8-K |
Current report
Listing notice
|
Feb 15, 2024 | Feb 13, 2024 |
| 25-NSE | Delisting notice | Feb 15, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jan 22, 2024 | — |
| 8-K |
Current report
Unregistered share sale
|
Jan 17, 2024 | Dec 5, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Jan 5, 2024 | Dec 5, 2023 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Jan 3, 2024 | Dec 5, 2023 |
| 4 | Insider transaction | Jan 2, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 14, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Dec 11, 2023 | Dec 5, 2023 |
| RW | Form rw | Dec 1, 2023 | — |
| 8-K |
Current report
Listing notice
|
Nov 27, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 22, 2023 | Nov 16, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| S-1/A | Amended registration statement | Nov 3, 2023 | — |
| S-1/A | Amended registration statement | Nov 1, 2023 | — |
| 4 | Insider transaction | Oct 30, 2023 | Jun 2, 2021 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 30, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 26, 2023 | Oct 26, 2023 |
| S-1 | Registration statement | Oct 4, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 9, 2023 | Aug 4, 2023 |
| EFFECT | Filing | Aug 3, 2023 | — |
| 424B3 | Prospectus | Aug 3, 2023 | — |
| CORRESP | Letter to the SEC | Aug 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2023 | — |
| S-3 | Shelf registration | Jul 28, 2023 | — |
| D | Filing | Jul 17, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 6, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 5, 2023 | — |
| RW | Form rw | Jun 28, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 14, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 14, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 14, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Listing notice
|
May 26, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Apr 5, 2023 | Apr 3, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Apr 5, 2023 | Apr 3, 2023 |
| S-1 | Registration statement | Mar 22, 2023 | — |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 4/A | Primary document | Feb 14, 2023 | Sep 14, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 14, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 4 | Insider transaction | Dec 21, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 21, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 13, 2022 |
| 4/A | Primary document | Dec 8, 2022 | Jul 28, 2022 |
| 4/A | Primary document | Dec 8, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2022 | Nov 22, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 14, 2022 |
| 4 | Insider transaction | Aug 31, 2022 | Aug 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2022 | Aug 23, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Aug 1, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 7, 2022 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Jul 5, 2022 | Jul 28, 2022 |
| 8-K | Current report | Jun 28, 2022 | Jun 22, 2022 |
| S-8 | Employee stock plan registration | Jun 22, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2022 | May 20, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2022 | Apr 19, 2022 |
| 10-K | Annual report | Apr 22, 2022 | Dec 31, 2021 |
| 10-Q/A | Amended quarterly report | Apr 21, 2022 | Sep 30, 2021 |
| 8-K |
Current report
Restatement
|
Apr 15, 2022 | Apr 13, 2022 |
| NT 10-K | Form nt10-k | Mar 31, 2022 | Dec 31, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 1, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 25, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Feb 16, 2022 | Feb 10, 2022 |
| 4 | Insider transaction | Feb 16, 2022 | Feb 9, 2022 |
| 4 | Insider transaction | Jan 28, 2022 | Jan 25, 2022 |
| 4 | Insider transaction | Jan 14, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 11, 2022 | Jan 10, 2022 |
| 8-K/A |
Amended current report
Auditor change
|
Dec 10, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Auditor change
|
Dec 9, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 4 | Insider transaction | Oct 25, 2021 | Oct 21, 2021 |
| 4 | Insider transaction | Oct 25, 2021 | Oct 21, 2021 |
| 4 | Insider transaction | Oct 25, 2021 | Oct 21, 2021 |
| 4 | Insider transaction | Oct 25, 2021 | Oct 21, 2021 |
| 4 | Insider transaction | Oct 25, 2021 | Oct 21, 2021 |
| 4 | Insider transaction | Oct 15, 2021 | Oct 12, 2021 |
| 4 | Insider transaction | Oct 15, 2021 | Oct 12, 2021 |
| 4 | Insider transaction | Oct 15, 2021 | Oct 12, 2021 |
| 4 | Insider transaction | Oct 15, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2021 | Oct 12, 2021 |
| 4/A | Primary document | Sep 28, 2021 | Jun 2, 2021 |
| DEFA14A | Additional proxy material | Sep 22, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2021 | Sep 16, 2021 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 16, 2021 | Nov 11, 2020 |
| DEF 14A | Proxy statement | Sep 13, 2021 | Oct 12, 2021 |
| EFFECT | Filing | Sep 3, 2021 | — |
| CORRESP | Letter to the SEC | Sep 1, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2021 | — |
| S-3 | Shelf registration | Aug 26, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jun 4, 2021 | Jun 2, 2021 |
| 4 | Insider transaction | Jun 4, 2021 | Jun 2, 2021 |
| 4 | Insider transaction | Jun 4, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 2, 2021 | May 27, 2021 |
| 424B4 | Prospectus | Jun 1, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZIVO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bloomfield Hills, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1101026
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (until Oct 16, 2014); WESTERN GLORY HOLE INC (until Jan 26, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.